FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Outlines IND Pilot to Speed Early Clinical Trials, Counter Overseas Competition

FDA outlines its intention to overhaul the early-stage clinical development process through a planned Expedited IND Pilot, arguing that the changes ar...

Animal Drugs

Antimicrobial Animal Drug Finalized Safety Guidance

FDA issues a finalized guidance on evaluating the safety of antimicrobial animal drugs based on their role in human medicine.

Human Drugs

Quantitative Medicine Innovation Network RFI

FDA seeks information from a variety of regulatory partners that will help it establish and implement a Quantitative Medicine Innovation Network.

Human Drugs

FDA, Tonix Align on Lyme Disease Prevention Phase 2 Study

FDA and Tonix Pharmaceuticals align on the protocol for an adaptive Phase 2 study of the companys TNX-4800 to prevent Lyme disease.

latest-news-card-1
Human Drugs

Inspection Flags Sterility and Quality Control Concerns at Zydus Lifesciences

An FDA inspection cites multiple manufacturing and quality system deficiencies at a Zydus Lifesciences Limited sterile manufacturing facility in Ahmed...

Human Drugs

FDA Approves Takedas Orzeyful for Narcolepsy Type 1

FDA approves Takedas Orzeyful as the first drug to treat all symptoms of narcolepsy type 1 in adults.

latest-news-card-1
Human Drugs

Fresenius Recalls Morphine Injection Syringe Lot Due to Labeling Mix-Up

Fresenius Kabi recalls one lot of Simplist (morphine sulfate injection USP) 2 mg/1 mL prefilled syringes after discovering a labeling mix-up that coul...

latest-news-card-1
Human Drugs

Dabur India CGMP Violations

FDA warns Dabur India Limited about CGMP violations in its production of finished drugs.

latest-news-card-1
Medical Devices

Quality System Issues at Koven Technologies

FDA warns St. Louis, MO-based Koven Technologies about QSMR issues in its manufacturing and marketing of the Bidop 3 Doppler.

latest-news-card-1
Human Drugs

Multiple Violations in Brunner Hygiene Unapproved New Drugs

FDA warns Germanys Thomas Brunner Hygiene about CGMP and other violations in its production of unapproved and misbranded antiperspirants.